341 related articles for article (PubMed ID: 24847207)
1. Fractalkine/CX3CR1 signaling during neuropathic pain.
Clark AK; Malcangio M
Front Cell Neurosci; 2014; 8():121. PubMed ID: 24847207
[TBL] [Abstract][Full Text] [Related]
2. Role of the immune system in neuropathic pain.
Malcangio M
Scand J Pain; 2019 Dec; 20(1):33-37. PubMed ID: 31730538
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine/CX3CR1 signalling in chronic pain and inflammation.
Clark AK; Staniland AA; Malcangio M
Curr Pharm Biotechnol; 2011 Oct; 12(10):1707-14. PubMed ID: 21466443
[TBL] [Abstract][Full Text] [Related]
4. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions.
Verge GM; Milligan ED; Maier SF; Watkins LR; Naeve GS; Foster AC
Eur J Neurosci; 2004 Sep; 20(5):1150-60. PubMed ID: 15341587
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine/CX3CR1 Contributes to Endometriosis-Induced Neuropathic Pain and Mechanical Hypersensitivity in Rats.
Liu Z; Chen S; Qiu C; Sun Y; Li W; Jiang J; Zhang JM
Front Cell Neurosci; 2018; 12():495. PubMed ID: 30622457
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine/CX
Silva R; Malcangio M
Front Pain Res (Lausanne); 2021; 2():684684. PubMed ID: 35295489
[TBL] [Abstract][Full Text] [Related]
8. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine.
Zhuang ZY; Kawasaki Y; Tan PH; Wen YR; Huang J; Ji RR
Brain Behav Immun; 2007 Jul; 21(5):642-51. PubMed ID: 17174525
[TBL] [Abstract][Full Text] [Related]
9. Neuropathic pain and cytokines: current perspectives.
Clark AK; Old EA; Malcangio M
J Pain Res; 2013; 6():803-14. PubMed ID: 24294006
[TBL] [Abstract][Full Text] [Related]
10. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.
Gao YJ; Ji RR
Pharmacol Ther; 2010 Apr; 126(1):56-68. PubMed ID: 20117131
[TBL] [Abstract][Full Text] [Related]
11. Microglial signalling mechanisms: Cathepsin S and Fractalkine.
Clark AK; Malcangio M
Exp Neurol; 2012 Apr; 234(2):283-92. PubMed ID: 21946268
[TBL] [Abstract][Full Text] [Related]
12. [Pathophysiology of low back pain and the transition to the chronic state - experimental data and new concepts].
Mense S
Schmerz; 2001 Dec; 15(6):413-7. PubMed ID: 11793144
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and pain mechanisms.
Abbadie C; Bhangoo S; De Koninck Y; Malcangio M; Melik-Parsadaniantz S; White FA
Brain Res Rev; 2009 Apr; 60(1):125-34. PubMed ID: 19146875
[TBL] [Abstract][Full Text] [Related]
14. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S.
Clark AK; Yip PK; Malcangio M
J Neurosci; 2009 May; 29(21):6945-54. PubMed ID: 19474321
[TBL] [Abstract][Full Text] [Related]
15. The induction of pain: an integrative review.
Millan MJ
Prog Neurobiol; 1999 Jan; 57(1):1-164. PubMed ID: 9987804
[TBL] [Abstract][Full Text] [Related]
16. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.
Milligan ED; Zapata V; Chacur M; Schoeniger D; Biedenkapp J; O'Connor KA; Verge GM; Chapman G; Green P; Foster AC; Naeve GS; Maier SF; Watkins LR
Eur J Neurosci; 2004 Nov; 20(9):2294-302. PubMed ID: 15525271
[TBL] [Abstract][Full Text] [Related]
17. Pathobiology of neuropathic pain.
Zimmermann M
Eur J Pharmacol; 2001 Oct; 429(1-3):23-37. PubMed ID: 11698024
[TBL] [Abstract][Full Text] [Related]
18. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain.
Lindia JA; McGowan E; Jochnowitz N; Abbadie C
J Pain; 2005 Jul; 6(7):434-8. PubMed ID: 15993821
[TBL] [Abstract][Full Text] [Related]
19. Microglia Mediate HIV-1 gp120-Induced Synaptic Degeneration in Spinal Pain Neural Circuits.
Ru W; Liu X; Bae C; Shi Y; Walikonis R; Mo Chung J; Tang SJ
J Neurosci; 2019 Oct; 39(42):8408-8421. PubMed ID: 31471472
[TBL] [Abstract][Full Text] [Related]
20. Protein kinases as potential targets for the treatment of pathological pain.
Ji RR; Kawasaki Y; Zhuang ZY; Wen YR; Zhang YQ
Handb Exp Pharmacol; 2007; (177):359-89. PubMed ID: 17087130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
